Jaguar Health, Inc. (JAGX) Insider Trading
Directors, officers and holders of more than 10% of JAGX report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 73 transactions on file: 7 with code P, 0 with code S and 43 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 11, 2025 | MICEK JOHN | Director | A Award | 7,377 | Not measured | Not measured |
| Dec 11, 2025 | BOCHNOWSKI JAMES J | Director | A Award | 12 | Not measured | Not measured |
| Dec 11, 2025 | MICEK JOHN | Director | A Award | 14 | Not measured | Not measured |
| Dec 11, 2025 | Lizak Carol R. | Chief Financial Officer | A Award | 11,740 | Not measured | Not measured |
| Dec 11, 2025 | Jayasuriya Anula | Director | A Award | 5,870 | Not measured | Not measured |
| Dec 11, 2025 | Siegel Jonathan B. | Director | A Award | 7,377 | Not measured | Not measured |
| Dec 11, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | A Award | 11,740 | Not measured | Not measured |
| Dec 11, 2025 | Wolin Jonathan S. | See Remarks | A Award | 11,740 | Not measured | Not measured |
| Dec 11, 2025 | King Steven R. | See Remarks | A Award | 22 | Not measured | Not measured |
| Dec 11, 2025 | CONTE LISA A | See Remarks | A Award | 54 | Not measured | Not measured |
| Dec 11, 2025 | Wolin Jonathan S. | See Remarks | A Award | 22 | Not measured | Not measured |
| Dec 11, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | A Award | 22 | Not measured | Not measured |
| Dec 11, 2025 | Siegel Jonathan B. | Director | A Award | 14 | Not measured | Not measured |
| Dec 11, 2025 | Jayasuriya Anula | Director | A Award | 11 | Not measured | Not measured |
| Dec 11, 2025 | Lizak Carol R. | Chief Financial Officer | A Award | 22 | Not measured | Not measured |
| Dec 11, 2025 | CONTE LISA A | See Remarks | A Award | 28,592 | Not measured | Not measured |
| Dec 11, 2025 | BOCHNOWSKI JAMES J | Director | A Award | 6,363 | Not measured | Not measured |
| Dec 11, 2025 | King Steven R. | See Remarks | A Award | 11,740 | Not measured | Not measured |
| Jun 24, 2025 | King Steven R. | See Remarks | A Award | 3,785 | $20.00 | $75,700 |
| Jun 24, 2025 | Siegel Jonathan B. | Director | D Disposition | 9,000 | $50000.00 | $450,000,000 |
| Jun 24, 2025 | Siegel Jonathan B. | Director | A Award | 9,462 | $50000.00 | $473,100,000 |
| Jun 24, 2025 | Siegel Jonathan B. | Director | A Award | 18,262 | Not measured | Not measured |
| Jun 24, 2025 | MICEK JOHN | Director | D Disposition | 9,000 | $50000.00 | $450,000,000 |
| Jun 24, 2025 | MICEK JOHN | Director | A Award | 9,462 | $50000.00 | $473,100,000 |
| Jun 24, 2025 | MICEK JOHN | Director | A Award | 18,262 | Not measured | Not measured |
| Jun 24, 2025 | BOCHNOWSKI JAMES J | Director | D Disposition | 27,002 | $150000.00 | $4,050,300,000 |
| Jun 24, 2025 | BOCHNOWSKI JAMES J | Director | A Award | 28,388 | $150000.00 | $4,258,200,000 |
| Jun 24, 2025 | BOCHNOWSKI JAMES J | Director | A Award | 54,786 | Not measured | Not measured |
| Jun 24, 2025 | King Steven R. | See Remarks | D Disposition | 3,600 | $20000.00 | $72,000,000 |
| Jun 24, 2025 | King Steven R. | See Remarks | A Award | 7,304 | Not measured | Not measured |
| Jun 24, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | D Disposition | 3,600 | $20000.00 | $72,000,000 |
| Jun 24, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | A Award | 3,785 | $20000.00 | $75,700,000 |
| Jun 24, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | A Award | 7,304 | Not measured | Not measured |
| Jun 24, 2025 | Wolin Jonathan S. | See Remarks | D Disposition | 9,000 | $50000.00 | $450,000,000 |
| Jun 24, 2025 | Wolin Jonathan S. | See Remarks | A Award | 9,462 | $50000.00 | $473,100,000 |
| Jun 24, 2025 | Wolin Jonathan S. | See Remarks | A Award | 18,262 | Not measured | Not measured |
| Jun 24, 2025 | CONTE LISA A | See Remarks | D Disposition | 9,000 | $50000.00 | $450,000,000 |
| Jun 24, 2025 | CONTE LISA A | See Remarks | A Award | 9,462 | $50000.00 | $473,100,000 |
| Jun 24, 2025 | CONTE LISA A | See Remarks | A Award | 18,262 | Not measured | Not measured |
| May 17, 2025 | King Steven R. | See Remarks | M Exercise | 0 | Not measured | Not measured |
| May 17, 2025 | CONTE LISA A | See Remarks | M Exercise | 2 | Not measured | Not measured |
| May 17, 2025 | CONTE LISA A | See Remarks | M Exercise | 0 | Not measured | Not measured |
| May 17, 2025 | King Steven R. | See Remarks | M Exercise | 1 | Not measured | Not measured |
| Mar 31, 2025 | Siegel Jonathan B. | Director | P Purchase | 9,000 | $50000.00 | $450,000,000 |
| Mar 31, 2025 | Siegel Jonathan B. | Director | P Purchase | 9,000 | Not measured | Not measured |
| Mar 31, 2025 | CONTE LISA A | See Remarks | P Purchase | 9,000 | $50000.00 | $450,000,000 |
| Mar 31, 2025 | CONTE LISA A | See Remarks | P Purchase | 9,000 | Not measured | Not measured |
| Mar 31, 2025 | Wolin Jonathan S. | See Remarks | P Purchase | 9,000 | $50000.00 | $450,000,000 |
| Mar 31, 2025 | Wolin Jonathan S. | See Remarks | P Purchase | 9,000 | Not measured | Not measured |
| Mar 31, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | P Purchase | 3,600 | $20000.00 | $72,000,000 |
The full Form 4 history is on the JAGX company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.